- Home
- FRMM vs DXR Comparison
FRMM vs DXR Comparison
Compare FRMM & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRMM | DXR |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8M | 59.0M |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FRMM | DXR |
|---|---|---|
| Price | $3.30 | $9.83 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | $11.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 91.1K | 13.0K |
| Earning Date | 11-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,547,000.00 | $1,446,345.00 |
| Revenue This Year | $119.07 | $44,489.33 |
| Revenue Next Year | $825.15 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.76 | $8.56 |
| 52 Week High | $7.15 | $14.76 |
Technical Indicators
Market Signals| Indicator | FRMM | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 20.91 | 36.44 |
| Support Level | $1.76 | $9.38 |
| Resistance Level | $5.12 | $12.07 |
| Average True Range (ATR) | 0.27 | 0.44 |
| MACD | -0.12 | -0.11 |
| Stochastic Oscillator | 1.48 | 4.00 |
Price Performance
Historical ComparisonAbout FRMM Forum Markets Incorporated Common Stock
Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.